Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
Concerned About Holiday Weight Gain? Prestige Men's Health Offers Affordable, Medically-Supervised Semaglutide Options for Qualifying Individuals - Featured image
Health

Concerned About Holiday Weight Gain? Prestige Men's Health Offers Affordable, Medically-Supervised Semaglutide Options for Qualifying Individuals

As the holiday season approaches, many individuals express concerns regarding potential weight gain. Prestige Men's Health in Holladay is offering medically supervised weight-loss programs using GLP-1 treatments like semaglutide, providing screening, labs, and continuous monitoring. This comes as more Utah residents seek medical guidance for weight management during this time.

Shotlee·December 11, 2025·Updated Jan 27, 2026·4 min read
Share:

Contents

  1. 01Holiday Weight Gain Concerns Addressed with Medically Supervised Semaglutide
  2. 02GLP-1 Medications: Semaglutide and Tirzepatide
  3. 03Costs, Eligibility, and Screening Processes
  4. 04The Importance of Medical Supervision for GLP-1 Weight Loss
  5. 05Telehealth Access in Utah and Licensed Neighboring States
  6. 06FAQ: GLP-1 Medications and Semaglutide

Holiday Weight Gain Concerns Addressed with Medically Supervised Semaglutide

With office parties, family gatherings, and numerous food-centric celebrations, gaining weight during the holiday season can seem unavoidable. For many, the anxiety surrounding this potential weight gain begins even before New Year's resolutions are made.

Clinicians at Prestige Men's Health in Holladay note that the annual trend of holiday weight gain is a factor driving increased interest in semaglutide, a GLP-1 prescription medication utilized in their medically supervised weight-loss programs.

Dr. Joshua Schmidt, M.D., founder of the clinic, stated that they have broadened their services to include supervised weight loss treatments. The clinic is also known for men's health services such as Low T and erectile dysfunction treatment.

GLP-1 Medications: Semaglutide and Tirzepatide

Dr. Schmidt explained, "Our decision to concentrate on these treatments is directly related to the rise of these innovative weight-loss protocols." These protocols encompass semaglutide-based drugs such as Ozempic and Wegovy, in addition to Mounjaro and Zepbound, which utilize tirzepatide, a different GLP-1 class compound.

According to Dr. Schmidt, both semaglutide and tirzepatide facilitate weight loss and blood-sugar regulation by slowing gastric emptying, resulting in prolonged satiety and decreased appetite. These injectables also stimulate receptors in the brain and pancreas, further reducing hunger. Health tracking apps like Shotlee can help monitor progress and side effects during such treatments.

While some individuals may experience manageable, primarily stomach-related side effects like nausea, constipation, or diarrhea that typically diminish over time, more serious complications are outlined in boxed warnings for GLP-1 based medicines, including a rare thyroid C-cell tumor risk observed in animal studies. Therefore, doctors will not prescribe them to individuals with certain thyroid cancer histories, something that is closely monitored.

Dr. Schmidt noted that the seasonal demand for weight loss solutions begins with Thanksgiving and continues through Christmas and New Year's. He also states that weight control is a year-round endeavor, and for many, it presents a significant challenge. He adds that supervised treatment options, when combined with diet and exercise, can promote clinically significant weight loss for suitable patients.

Costs, Eligibility, and Screening Processes

The clinic aims to provide transparent and predictable pricing. Prestige Men's Health provides complimentary consultations to assess a patient's eligibility for medication-based weight management. Initial lab work typically costs around $30. Continuous care is approximately $80 per month, with multi-month plans averaging about $70 per month, depending on the chosen plan.

To qualify, patients must undergo a medical assessment and lab testing before commencing medication, with continuous monitoring throughout the treatment period.

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

According to Dr. Schmidt, these medications are not a quick fix, but rather tools that are most effective when integrated into a comprehensive plan.

The Importance of Medical Supervision for GLP-1 Weight Loss

Dr. Schmidt emphasized that GLP-1 medications are not suitable for everyone. FDA prescribing guidelines for semaglutide and tirzepatide specify medical screening requirements, gradual dosing regimens, and the necessity for ongoing monitoring.

Potential side effects can include digestive issues, and prescribing labels caution against rarer but more severe risks. Patients should discuss their medical history with a licensed healthcare professional before initiating any prescription weight-loss medication.

Telehealth Access in Utah and Licensed Neighboring States

Most patients begin with either an in-person or telehealth consultation. If eligible, lab testing is scheduled before starting medication. Telehealth weight-loss consultations are available for qualifying patients throughout Utah, including Salt Lake County and the Wasatch Front, as well as licensed neighboring states. Labs are conducted locally, and medications are supplied via shipment or a local pharmacy, when appropriate.

FAQ: GLP-1 Medications and Semaglutide

What is a GLP-1 medication?

GLP-1 medications are prescription drugs designed to regulate appetite and blood sugar levels. They can aid in weight loss when used under the guidance of a healthcare professional.

Is semaglutide safe for all individuals?

No. Semaglutide and other GLP-1 medications have specific eligibility criteria and potential side effects. A clinician must assess a patient's suitability for the medication.

How rapidly do individuals experience weight loss?

Results can vary. Clinical trials indicate average weight-loss outcomes, but individual results may depend on factors such as medical history, dosage, and lifestyle.

Is it necessary to reside near Holladay?

No. Telehealth consultations are available for eligible patients throughout Utah and in appropriately licensed states.

Original source: Gephardt Daily

View original article →
#holiday weight gain#semaglutide#GLP-1#weight loss#medical supervision#Prestige Men's Health#Utah#telehealth
  1. Home
  2. Blog
  3. Concerned About Holiday Weight Gain? Prestige Men's Health Offers Affordable, Medically-Supervised Semaglutide Options for Qualifying Individuals

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community